new directions in targeting angiogenesis for metastatic colorectal cancer
Published 9 years ago • 123 plays • Length 22:30Download video MP4
Download video MP3
Similar videos
-
18:58
mechanisms of angiogenesis inhibitors in metastatic colorectal cancer
-
15:55
enhancing outcomes in metastatic colorectal cancer with angiogenesis inhibitors
-
13:14
targeting angiogenesis in gi malignancies
-
41:03
part 1: clinical utility of angiogenesis inhibitors in metastatic colorectal cancer
-
32:17
part 2: clinical utility of angiogenesis inhibitors in metastatic colorectal cancer
-
10:49
part 3: clinical utility of angiogenesis inhibitors in metastatic colorectal cancer
-
14:29
targeting her 2 and angiogenesis in gastric cancer: what is the impact
-
4:19
antiangiogenic treatments for metastatic colorectal cancer
-
23:57
a comparison of angiogenesis inhibitor trial designs and outcomes in mcrc
-
35:27
expert perspectives: optimizing late-line therapy for patients with metastatic colorectal cancer
-
6:32
antiangiogenic therapy for metastatic colorectal cancer
-
15:48
targeting her 2 and angiogenesis in gastric cancer: what is the impact?
-
2:01
dr. fuchs on targeting angiogenesis in gastric cancer
-
10:54
metastatic gastric cancer: indications and impact of angiogenesis inhibitors
-
15:52
debate: are novel targets such as her2 ready for prime time in colorectal cancer? - no
-
3:23
colorectal cancer and the role of angiogenesis in cancer development
-
22:35
expert perspectives: anti-angiogenesis and immune therapy for cancer
-
7:36
angiogenesis in tumor growth and metastasis
-
12:16
selecting the optimal first-line treatment in advanced colorectal cancer